Curriculum
Module 09 · 60 min

Probiotics & the Gut — Strain-Specific Reality

Why 'probiotic' is too broad a word to support most claims.

CoreClinicalAdvanced
Core topics

Lessons in this module

Learning objectives

By the end of this module you will be able to

Lesson summary ↓Graded claims ↓Self-check ↓Vignettes ↓Glossary ↓
  • L01
    State that probiotic effects are strain-specific, not class effects.
  • L02
    Identify which probiotic strains have RCT support for specific indications.
  • L03
    Recall the PROSPECT trial and why probiotics are not routine in ICU.
  • L04
    Counsel skeptically on 'gut health' marketing.
Expected takeaways

What you should walk away believing

  • →Probiotic effects are strain-specific — extrapolating from one product to another is not supported.
  • →Saccharomyces boulardii reduces antibiotic-associated diarrhea modestly.
  • →VSL#3 (now Visbiome) has evidence in ulcerative colitis maintenance and pouchitis.
  • →Probiotics are not benign in critically ill or immunocompromised patients (fungemia case reports).
Lesson · Core emphasis

What this means for you

Patient summary

'Probiotic' is a broad word — there are many different bacteria and yeasts, and they don't all do the same thing. Some specific products help with specific problems. Most yogurt and drink marketing isn't supported by trials.

Clinician summary

Match strain to indication: S. boulardii (AAD), Lactobacillus rhamnosus GG (pediatric AAD — mixed adult data), B. infantis 35624 (IBS), Visbiome (UC maintenance, pouchitis). Avoid in central-line patients, neutropenic, severe acute pancreatitis (PROPATRIA).

Advanced note

PROPATRIA (Besselink 2008) showed increased mortality from probiotics in severe acute pancreatitis. PROSPECT (Johnstone 2021) showed no benefit in ventilated ICU patients. Strain-specific microbiome effects often modest and transient.

Evidence framework

Where this module sits on the device evidence map

Probiotics: a few strain-indication pairs work; broad marketing claims do not.

Tier map →Tier 1 →Tier 2 →Tier 3 →Tier 4 →
Myth-buster

All probiotics improve 'gut health'.

Reality

Strain-specific; many products have no RCT for any specific indication.

Evidence-graded claims

What the data says

B
S. boulardii reduces antibiotic-associated diarrhea
Meta-analyses positive.
F
Probiotics improve outcomes in severe acute pancreatitis
PROPATRIA — increased mortality.
E
Generic 'probiotic yogurt' improves immune function
Strain/dose typically inadequate.
Objective self-check

Test the learning objectives

Score0 / 1(0 answered)
Q1L01 — Probiotic effects are:
Case vignettes

Apply it: real-world counseling scenarios

Short patient encounters that test your judgment, not your recall. Pick the most defensible response, then reveal the rationale and a sample coaching script you could actually say at the bedside.

Vignette proficiency
In progress · 0/1 submitted
Correct0/1 (0%)Pitfalls avoided0/0 (0%)Composite0
Composite weighting
Accuracy 60%Pitfalls 40%
← all pitfallsbalancedall accuracy →
Composite = 60% answer accuracy + 40% pitfalls avoided. Your weighting is saved for this module.
Order · randomized[1]
Vignette 1 of 1· source #1

ICU probiotic order

Objective · Apply PROSPECT/PROPATRIA caution.

A bedside nurse asks if you'll start a generic 'probiotic for gut support' on a ventilated septic patient.

Best response?
Quick check

Test yourself

Q1PROPATRIA finding?
Q2Best-evidence strain for IBS?
Flashcards · Spaced repetition

Lock it in — review what's due

Due2Total2
FrontNew
2 in queue
Strain-specific or class effect?
Click to reveal answer
Glossary

Key terms & abbreviations

CFU
Colony-forming units — viable microbe count; declines through shelf life.
Postbiotic
Bioactive compounds produced by microbes during fermentation; emerging category, limited RCT data.
Further reading

Optional deeper dive

Previous
Omega-3 Fatty Acids — EPA, DHA & the AF Signal
Next
Herbals & Botanicals — Curcumin, St John's Wort, Ashwagandha